Key result
Simultaneous clearances of unlabeled porcine insulin and radioiodinated insulin yielded disparate results, creating uncertainty in estimating insulin delivery.
Why the study?
How does metabolic clearance of insulin vary among normal, diabetic, and obese subjects, and between radioiodinated and unlabeled insulin?
Observational
How does metabolic clearance of insulin vary among normal, diabetic, and obese subjects, and between radioiodinated and unlabeled insulin?
There is a significant discrepancy between the metabolic clearance rates of radioiodinated and unlabeled insulin, complicating the estimation of peripheral insulin delivery.
Answers are grounded in this paper and cite their sources.
Radioiodinated insulin underestimates clearance vs unlabeled; leaves open reliable assessment of peripheral insulin delivery in diabetes and obesity.
Metabolic clearance of insulin was measured, under circumstances of acutely and chronically altered endogenous plasma insulin, employing 1-131 bovine insulin (5 mc./mg., Abbott Laboratories) as tracer and the technic of constant infusion to equilibrium. Compared to normal subjects, clearance of radioiodinated insulin was unaffected by diabetes, was increased 25 per cent in obese subjects with hyperinsulinemia and did not change when their plasma insulin was reduced by seven days of fasting. Acute fourto fifteenfold elevation of endogenous insulin by glucose or tolbutamide injections to normal and obese subjects also failed to change clearance of radioiodinated insulin. These data support the assumption that alterations of plasma insulin in those circumstances largely reflect alterations in insulin secretion. However, in both normal and diabetic subjects, simultaneous clearances of unlabeled porcine insulin and radioiodinated insulin were also performed and disparate results obtained. Mean values were: unlabeled 861 ml./min. (Normals), 788 ml./min. (Diabetics) ; radioiodinated 227 ml./min. (Normals) ; 202 ml./min. (Diabetics). Ratio of unlabeled to radioiodinated clearance 3.8 (Normals), 4.1 (Diabetics). Because of this discrepancy, it is uncertain which clearance value affords the more accurate estimate of peripheral insulin delivery rate.
No takes yet. Share an insight, caveat, or question.
Saul Genuth (1972) conducted an observational in Diabetes and obesity. Radioiodinated and unlabeled insulin infusion vs. Normal subjects was evaluated on Metabolic clearance of insulin. Simultaneous clearances of unlabeled porcine insulin and radioiodinated insulin yielded disparate results, creating uncertainty in estimating insulin delivery.
Synapse has enriched 10 related papers. Consider them for comparative context: